Literature DB >> 5903829

Normal retinal vascular pattern. Arteriovenous ratio as a measure of arterial calibre.

N L Stokoe, R W Turner.   

Abstract

Mesh：

Year:  1966        PMID： 5903829      PMCID： PMC506185          DOI： 10.1136/bjo.50.1.21

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  A method of grading and recording; the retinal changes in essential hypertension.

Authors:  K A EVELYN; J V NICHOLIS; W TURNBULL
Journal:  Am J Ophthalmol       Date:  1958-04       Impact factor: 5.258

2.  The retina in hypertensive disease.

Authors:  S A SHELBURNE
Journal:  Ann Intern Med       Date:  1957-12       Impact factor: 25.391

3.  SCLEROSIS OF THE RETINAL VESSELS.

Authors:  N Pines
Journal:  Br J Ophthalmol       Date:  1929-04       Impact factor: 4.638

4.  The retinal vessels in hypertensive disease.

Authors:  R LEISHMAN
Journal:  Proc R Soc Med       Date:  1952-07

5.  The ophthalmoscopical appearance of the fundus oculi in elderly persons with arteriosclerosis and normal blood pressures.

Authors:  H VOGELIUS; P BECHGAARD
Journal:  Br J Ophthalmol       Date:  1950-07       Impact factor: 4.638

6.  Classification of Retinal Lesions in the Presence of Vascular Hypertension: Report submitted to the American Ophthalmological Society by the committee on Classification of Hypertensive Disease of the Retina.

Authors:  H P Wagener; G E Clay; J F Gipner
Journal:  Trans Am Ophthalmol Soc       Date:  1947
  6 in total
  10 in total

Review 1.  Hypertension and the eye.

Authors:  James S Wolffsohn; Peter G Hurcomb
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

2.  Retinal artery changes correlated with other hypertensive parameters in a coronary heart disease case-history study.

Authors:  P O'Sullivan; N Hickey; B Maurer; P Guinan; R Mulcahy
Journal:  Br Heart J       Date:  1968-07

3.  Artery/vein classification of retinal vessels using classifiers fusion.

Authors:  Samra Irshad; Xiao-Xia Yin; Yanchun Zhang
Journal:  Health Inf Sci Syst       Date:  2019-11-08

4.  Signs in the fundus oculi and arterial hypertension: unconventional assessment and significance.

Authors:  A Kagan; E Aurell; G Tibblin
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

5.  Histopathological assessments reveal retinal vascular changes, inflammation and gliosis in patients with lethal COVID-19.

Authors:  Vijay K Jidigam; Rupesh Singh; Julia C Batoki; Caroline Milliner; Onkar B Sawant; Vera L Bonilha; Sujata Rao
Journal:  medRxiv       Date:  2021-02-28

6.  Histopathological assessments reveal retinal vascular changes, inflammation, and gliosis in patients with lethal COVID-19.

Authors:  Vijay K Jidigam; Rupesh Singh; Julia C Batoki; Caroline Milliner; Onkar B Sawant; Vera L Bonilha; Sujata Rao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-29       Impact factor: 3.117

7.  Ebstein anomaly associated with retinal venular dilatation, migraine, and visual snow syndrome: a case report.

Authors:  P T V M de Jong; E F Thee; B Straver
Journal:  BMC Ophthalmol       Date:  2022-02-14       Impact factor: 2.209

Review 8.  Variability in Retinal Neuron Populations and Associated Variations in Mass Transport Systems of the Retina in Health and Aging.

Authors:  Moussa A Zouache
Journal:  Front Aging Neurosci       Date:  2022-02-25       Impact factor: 5.750

9.  The application of arterio-venous ratio (AVR) cut-off values in clinic to stratify cardiovascular risk in patients.

Authors:  Christian French; Robert Peter Cubbidge; Rebekka Heitmar
Journal:  Ophthalmic Physiol Opt       Date:  2022-03-07       Impact factor: 3.992

10.  A Deep Learning Architecture for Vascular Area Measurement in Fundus Images.

Authors:  Kanae Fukutsu; Michiyuki Saito; Kousuke Noda; Miyuki Murata; Satoru Kase; Ryosuke Shiba; Naoki Isogai; Yoshikazu Asano; Nagisa Hanawa; Mitsuru Dohke; Manabu Kase; Susumu Ishida
Journal:  Ophthalmol Sci       Date:  2021-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.